Evidence map›Paper›PMID 41214190›Full record

ArticleScientific reports2025

Risk factors for early mortality among HIV-positive adults on antiretroviral therapy in Ethiopian health facilities.

Birhanu Yadecha, Getahun Fetensa, Mitsiwat Abebe, Mulugeta Mekuria

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Birhanu YadechaDepartment of Nursing, Ambo University, Waliso, Ethiopia. birhanuyad@gmail.com.
Getahun FetensaDepartment of Nursing, St Paul millennium medical college, Addis Ababa, Ethiopia.
Mitsiwat AbebeDepartment of Public Health, Ambo University, Ambo, Ethiopia.
Mulugeta MekuriaDepartment of Public Health, Ambo University, Ambo, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rapid expansion of antiretroviral therapy (ART) in Ethiopia has significantly reduced AIDS-related deaths; however, survival rates among people living with HIV (PLHIV) on ART remain variable, and findings on predictors of early mortality are inconsistent. This study aimed to identify factors associated with early mortality among ART users in the Woliso district of Ethiopia. A historical cohort study was conducted among 720 randomly selected ART users from January 2018 to December 2022. Data were collected using Open Data Kit (ODK) and analyzed with STATA 13. Kaplan-Meier survival analysis and Cox proportional hazards regression were employed to assess predictors of mortality. The mortality incidence density was 5.1 per 100 person-years (95% CI: 4.01-6.50). Significant predictors of early mortality included being divorced (AHR: 6.34; 95% CI: 2.05-19.65), advanced WHO clinical stage III/IV (AHR: 2.92; 95% CI: 1.12-8.27), and suboptimal ART adherence-fair (AHR: 5.48; 95% CI: 2.37-12.66) and poor (AHR: 3.50; 95% CI: 1.72-7.09). This study highlights a high early mortality rate, emphasizing the need for early HIV care enrollment and strict treatment adherence to improve survival. Strengthening ART programs with targeted interventions for high-risk groups, such as divorced individuals and those with advanced disease, could further reduce mortality in Ethiopia.

Indexed as

Anti-HIV AgentsAnti-Retroviral AgentsHIV InfectionsAdultAntiretroviral Therapy, Highly ActiveCohort StudiesEthiopiaFemaleHealth FacilitiesHumansKaplan-Meier EstimateMaleMiddle AgedProportional Hazards ModelsRisk FactorsYoung AdultAnti-HIV AgentsAnti-Retroviral AgentsARTPredictorsSurvival timeTime to eventWoliso district

Identifiers

PMID41214190
PMCPMC12603309

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.